Apply for the Master of Clinical Pharmacy (MClinPharm)Apply Now
The Master of Clinical Pharmacy (MClinPharm) degree comprises both advanced-level taught papers and a research component and is designed for registered pharmacists working in professional areas such as community pharmacy, hospital pharmacy and industrial pharmacy who require advanced level knowledge and research skills to progress their careers.
The Master of Clinical Pharmacy (MClinPharm) is also available through Distance Learning.
Information for new applicants
The Master of Clinical Pharmacy is intended for students who have completed a Postgraduate Diploma in Clinical Pharmacy (PGDipClinPharm) and wish to advance to a higher postgraduate level with a research component. Students who completed the PHCX 512 Advanced Clinical Pharmacy paper during the PGDipClinPharm are required to complete the thesis rather than the dissertation during the MClinPharm.
It is important to make contact with the Associate Dean of the Postgraduate Professional Programmes to discuss research options before embarking on the programme. The first year of the programme is taught papers, and the second year is the research component.
You will then need to complete the online application process to apply for the MClinPharm programme and select your papers. This is the usual enrolment process that starts with an online application and ends with a form for course approval. This form needs to be signed by the Associate Dean.
Summary of application process:
- Contact the Associate Dean.
- Submit an online application form.
- When you receive your Form for Course Approval, forward this to the School for signing by the appropriate Dean.
Associate Dean PPP, Professor Pauline Norris
School of Pharmacy
Level 5, Adams Building
18 Frederick Street, Dunedin
Professor Pauline Norris
School of Pharmacy
University of Otago
PO Box 56, Dunedin 9054
Tel 64 3 479 7359
Fax 64 3 479 7034
Regulations for the Degree of Master of Clinical Pharmacy (MClinPharm)
1 Admission to the Programme
(a) Admission to the programme shall be subject to the approval of the Pro-Vice-Chancellor (Health Sciences).
(b) Every applicant shall hold the Postgraduate Diploma in Clinical Pharmacy or have an equivalent qualification or experience acceptable to the Pro-Vice-Chancellor (Health Sciences), and be registered for practice as a pharmacist in the country of residence.
2 Structure of the Programme
(a) The degree may be achieved either
- by passing PHCX 506 and PHCX 512, and submitting a research dissertation (PHCX 590).
- by passing PHCX 506 and submitting a thesis (PHCY 5A) having previously passed PHCX 512.
(b) With the permission of the Dean of Pharmacy, candidates may substitute papers of other subjects for some of the required papers.
(c) A candidate shall, before beginning the programme of study, secure the approval of the Dean of Pharmacy for the subject and supervisors of the dissertation.
3 Terms Requirements
(a) No candidate will be eligible to sit a paper in a final examination without having gained terms in that paper.
(b) A candidate gains terms in a paper by satisfactorily demonstrating the acquisition of sufficient knowledge and skills, by attendance at classes, and by performance in a professional manner of such practical/clinical and other work as the School of Pharmacy may require.
(c) A candidate who fails to gain terms in any paper will, if other regulations have been met, be required to repeat the whole of that paper.
(d) Terms granted in any paper shall mormally be for the year only.
4 Duration of the Programme
A candidate may complete the programme after the equivalent of one year of full-time study and shall normally be required to complete within four years of part-time study.
5 Special Examinations
A candidate who obtains a D grade in a paper may be permitted to sit a special examination for that paper. Any candidate who has obtained an E grade in a paper will not normally be admitted to a special examination in that paper but may be offered an opportunity to repeat the paper.
6 Examination of the Thesis
(a) Every thesis shall be assessed by at least two examiners, at least one of whom shall be external to the University.
(b) The candidate's supervisors shall not be examiners but may make a report on the work of the candidate to the Dean of Pharmacy.
(c) Each examiner shall supply a written report on the thesis and recommend a mark and grade on the basis of the thesis as submitted, and an overall result selected from the options specified in clause (d) below.
(d) The examiners may recommend that a thesis:
(i) be accepted without amendments;
(ii) be accepted subject to amendments made at the discretion and to the satisfaction of the Dean of Pharmacy;
(iii) does not meet the criteria for the award of the degree, but may be revised and resubmitted for examination;
(iv) does not the criteria for the award of the degree, and should be rejected without right of resubmission.
(e) Amendments (regulation 5(d)(ii)) and revisions (regulation 5(d)(iii)) shall be completed by a specified date to be determined by the Dean of Pharmacy.
(f) A candidate shall be permitted to revise and resubmit a thesis for examination once only.
(g) If a revised and resubmitted thesis is finally accepted, the result shall be either Pass or Fail (i.e. ungraded) and without eligibility for the award of the degree with distinction or credit.
Note: This provision applies only to students who first enrol for the degree in 2009 or subsequently.
(h) Where examiners cannot agree on a result, the Dean of Pharmacy should so report to the Pro-Vice-Chancellor (Health Sciences) who shall arrive at a decision after consulting a referee who should normally be external to the University.
7 Level of Award of the Degree
The degree may be awarded with distinction or with credit.
The Pro-Vice-Chancellor (Health Sciences) may in exceptional circumstances approve a course of study which does not comply with these regulations.